Safety and Efficacy Results of a Phase I, Open-Label Study of Concurrent and Delayed Nivolumab in Combination With nab-Paclitaxel and Carboplatin in Advanced Non-Small Cell Lung Cancer User montaukwhaler, in the non small cell lung cancer subreddit, 05 Nov 2019